Overview
RNA Horizons 2026 will take place on 16–18 September 2026 in Munich, Germany. The conference serves as a multidisciplinary platform for scientists, healthcare professionals, pharmaceutical and biotechnology companies, investors, and innovators working across the RNA ecosystem.
The scientific program will cover key areas including RNA processing and mis-splicing in human disease, epitranscriptomic regulation, RNA-based immune modulation, mRNA vaccines, personalized RNA immunotherapy, RNA therapeutics for genetic and rare disorders, RNA biomarkers, precision medicine, RNA delivery technologies, non-coding RNAs as drug targets, and the application of artificial intelligence in RNA medicine.
Through plenary presentations, scientific sessions, panel discussions, and networking opportunities, RNA Horizons 2026 aims to foster collaboration between academia and industry, accelerate the translation of RNA discoveries into clinical applications, and support the development of next-generation therapies that address unmet medical needs.